Keywords: zeffix, effective, hbv, children, biochem, pharma, says
Zeffix effective for HBV in children
Article | 24 April 2001
BioChem Pharma says that its oral antiviral Zeffix (lamivudine),licenced to GlaxoSmithKline, is effective at suppressing hepatitis B in children. ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
